Regulatory and Mechanistic Actions of Glucocorticoids on T and Inflammatory Cells
Open accessThe DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Glucocorticoids (GCs) play an important role in regulating the inflammatory and immune response and have been used since decades to treat various inflammatory and autoimmune disorders. Fine-tuning the glucocorticoid receptor (GR) activity is instrumental in the search for novel therapeutic strategies aimed to reduce pathological signaling and restoring homeostasis. Despite the primary anti-inflammatory actions of GCs, there are studies suggesting that under certain conditions GCs may also exert pro-inflammatory responses. For these reasons the understanding of the GR basic mechanisms of action on different immune cells in the periphery (e.g., macrophages, dendritic cells, neutrophils, and T cells) and in the brain (microglia) contexts, that we review in this chapter, is a continuous matter of interest and may reveal novel therapeutic targets for the treatment of immune and inflammatory response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
NF-κB, Inflammation, and Metabolic Disease
Baker, R. G., Hayden, M. S., & Ghosh, S. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.008 · Cited by 1,952
Immune regulation by glucocorticoids
Cain, D. W., & Cidlowski, J. A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.1 · Cited by 1,846
T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
Yang, X. O., Pappu, B. P., Nurieva, R., Akimzhanov, A., Kang, H. S., Chung, Y., Ma, L., Shah, B., Panopoulos, A. D., Schluns, K. S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.016 · Cited by 1,605
p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068 · cited 1×
“GC-induced apoptosis of T cells requires the dimerization of the GR (133) and is mediated via the induction of Puma and Bim expression (134–137).”
BackgroundBid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
Yin, X.-M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K. A., & Korsmeyer, S. J. (1999) · Nature · doi:10.1038/23730 · Cited by 1,004
Cytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999
Glucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
Binder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977
Chromatin accessibility pre-determines glucocorticoid receptor binding patterns
John, S., Sabo, P. J., Thurman, R. E., Sung, M.-H., Biddie, S. C., Johnson, T. A., Hager, G. L., & Stamatoyannopoulos, J. A. (2011) · Nature Genetics · doi:10.1038/ng.759 · Cited by 954 · cited 1×
“In addition, chromatin accessibility has been reported to pre-determine GR binding patterns and, therefore, is critical for cell-specific outcome, providing new molecular basis for the tissue selectivity (95, 96).”
BackgroundDe Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Woodruff, P. G., Boushey, H. A., Dolganov, G. M., Barker, C. S., Yang, Y. H., Donnelly, S., Ellwanger, A., Sidhu, S. S., Dao-Pick, T. P., Pantoja, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707413104 · Cited by 828 · cited 1×
“Moreover, in a genome-wide profiling focused on the identification of epithelial gene markers of asthmatic patients and response to corticosteroids, GC treatment was found to induce FKBP51 expression, which in turn was associated with a poor response to corticosteroids, suggesting a role of FKBP51 in GC resistance (66…”
BackgroundScheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.943 · Cited by 819 · cited 2×
“However, transactivation is also necessary for the induction of several anti-inflammatory genes, such as MAP kinase phosphatase 1 (101), glucocorticoid-induced leucine zipper (102), and inhibitor kappa B-alpha (IĸBα) (85).”
BackgroundBledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00817-6 · Cited by 818
D'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675
Gene–Stress–Epigenetic regulation of FKBP5: clinical and translational implications
Zannas, A. S., Wiechmann, T., Gassen, N. C., & Binder, E. B. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.235 · Cited by 622
Genomic and nongenomic effects of glucocorticoids
Stahn, C., & Buttgereit, F. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0898 · Cited by 594
Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., Chwalinska-Sadowska, H., & Maslinski, W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2832 · Cited by 580
Frank, M. G., Baratta, M. V., Sprunger, D. B., Watkins, L. R., & Maier, S. F. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.03.005 · Cited by 578
Surjit, M., Ganti, K. P., Mukherji, A., Ye, T., Hua, G., Metzger, D., Li, M., & Chambon, P. (2011) · Cell · doi:10.1016/j.cell.2011.03.027 · Cited by 551 · cited 1×
“Furthermore, GR-mediated transcriptional repression can be exerted via GR binding to a negative GRE (nGRE) (79).”
BackgroundWatkins, L. R., Goehler, L. E., Relton, J. K., Tartaglia, N., Silbert, L., Martin, D., & Maier, S. F. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11105-r · Cited by 516
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme
Masferrer, J. L., Seibert, K., Zweifel, B., & Needleman, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3917 · Cited by 461
The Stressed CNS: When Glucocorticoids Aggravate Inflammation
Sorrells, S. F., Caso, J. R., Munhoz, C. D., & Sapolsky, R. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.032 · Cited by 425
Ratman, D., Vanden Berghe, W., Dejager, L., Libert, C., Tavernier, J., Beck, I. M., & De Bosscher, K. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.12.014 · Cited by 411
FRANCHIMONT, D. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.009 · Cited by 408
Oakley, R. H., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.179325 · Cited by 373
Busillo, J. M., & Cidlowski, J. A. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.11.005 · Cited by 339
Croxtall, J. D., Choudhury, Q., & Flower, R. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703272 · Cited by 332 · cited 1×
“On the other hand, binding of GCs to GR can modify the recruitment of different factors such as the multiprotein chaperone complex that participate in many signaling pathways, modifying secondary signaling cascades and, therefore, may further regulate the immune response (78, 83).”
BackgroundMacPhee, I. A., Antoni, F. A., & Mason, D. W. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.2.431 · Cited by 328
Carbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silberstein, S., Stalla, G. K., Holsboer, F., & Arzt, E. (2007) · Cell · doi:10.1016/j.cell.2007.07.044 · Cited by 318
Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses
Frank, M. G., Thompson, B. M., Watkins, L. R., & Maier, S. F. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.10.005 · Cited by 310 · cited 1×
“Treatment in vivo with RU486 and adrenalectomized inhibited the microglial pro-inflammatory response, indicating that stress-induced GCs are able to sensitize the microglial pro-inflammatory function (185, 186).”
BackgroundFrank, M. G., Miguel, Z. D., Watkins, L. R., & Maier, S. F. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.07.008 · Cited by 303 · cited 1×
“GCs were also found to upregulate microglial activation markers including the toll-like receptor 2 pro-inflammatory pathway (178, 181) (Figure 3A).”
BackgroundBeck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor.
Bertini, R., Bianchi, M., & Ghezzi, P. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.5.1708 · Cited by 291
Minireview: Latest Perspectives on Antiinflammatory Actions of Glucocorticoids
De Bosscher, K., & Haegeman, G. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0283 · Cited by 284
Munhoz, C. D., Lepsch, L. B., Kawamoto, E. M., Malta, M. B., Lima, L. D. S., Werneck Avellar, M. C., Sapolsky, R. M., & Scavone, C. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4398-05.2006 · Cited by 274
Prior Stressor Exposure Sensitizes LPS-Induced Cytokine Production
Johnson, J. D., O'Connor, K. A., Deak, T., Stark, M., Watkins, L. R., & Maier, S. F. (2002) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0638 · Cited by 270
FKBP51 and FKBP52 in signaling and disease
Storer, C. L., Dickey, C. A., Galigniana, M. D., Rein, T., & Cox, M. B. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.08.001 · Cited by 266 · cited 2×
“Moreover, in a genome-wide profiling focused on the identification of epithelial gene markers of asthmatic patients and response to corticosteroids, GC treatment was found to induce FKBP51 expression, which in turn was associated with a poor response to corticosteroids, suggesting a role of FKBP51 in GC resistance (66…”
BackgroundGlucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome
Busillo, J. M., Azzam, K. M., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.275370 · Cited by 264 · cited 3×
“This effect was specific for GCs and dependent on the GR and suggests that GCs sensitize the initial inflammatory response in the context of acute cellular damage or death (32).”
BackgroundZimmermann, P., Brückl, T., Nocon, A., Pfister, H., Binder, E. B., Uhr, M., Lieb, R., Moffitt, T. E., Caspi, A., Holsboer, F., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111577 · Cited by 262
Gene regulation by the glucocorticoid receptor: structure:function relationship
Kumar, R., & Thompson, E. B. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.046 · Cited by 261
Madrigal, J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00292-5 · Cited by 232
Stress increases vulnerability to inflammation in the rat prefrontal cortex
de Pablos, R. M., Villarán, R. F., Argüelles, S., Herrera, A. J., Venero, J. L., Ayala, A., Cano, J., & Machado, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0802-06.2006 · Cited by 215
The structural basis of direct glucocorticoid- mediated transrepression
Hudson, W. H., Youn, C., & Ortlund, E. A. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2456 · Cited by 200 · cited 1×
“Binding to these nGRE prevent receptor dimerization through a strong negative cooperativity and alters the conformation of GR residues that are critical for transcriptional activation so that negative regulation is accomplished (80).”
BackgroundGlucocorticoids Play a Fundamental Role in Protecting the Brain during Innate Immune Response
Nadeau, S., & Rivest, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05536.2003 · Cited by 190
Cooper, M. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1412 · Cited by 183
Human Glucocorticoid Receptor β Binds RU-486 and Is TranscriptionallyActive
Lewis-Tuffin, L. J., Jewell, C. M., Bienstock, R. J., Collins, J. B., & Cidlowski, J. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01439-06 · Cited by 175
Cohen, N., Mouly, E., Hamdi, H., Maillot, M.-C., Pallardy, M., Godot, V., Capel, F., Balian, A., Naveau, S., Galanaud, P., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2760 · Cited by 170
Kleiman, A., & Tuckermann, J. P. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.009 · Cited by 165
Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger
Frank, M. G., Watkins, L. R., & Maier, S. F. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.02.004 · Cited by 160 · cited 1×
“Therefore, stress may act “priming” central innate immunity to a subsequent immune challenge by making the neuroimmune context more responsive to inflammation, also favoring GC insensitivity or reducing the HPA response (187).”
BackgroundSelective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor
Lu, N. Z., Collins, J. B., Grissom, S. F., & Cidlowski, J. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00253-07 · Cited by 160 · cited 1×
“Considering that GRβ can inhibit GRα activity, the modulation of GRα/GRβ expression ratios may be an interesting approach to regulate GC sensitivity (42, 43).”
BackgroundPotentiation of glucocorticoid receptor transcriptional activity by sumoylation
Le Drean, Y., Mincheneau, N., Le Goff, P., & Michel, D. (2002) · Endocrinology · doi:10.1210/en.2002-220135 · Cited by 159
Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain
Madrigal, J. L. M., Moro, M. A., Lizasoain, I., Lorenzo, P., Fernández, A. P., Rodrigo, J., Boscá, L., & Leza, J. C. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300187 · Cited by 155
Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection
Ruzek, M. C., Pearce, B. D., Miller, A. H., & Biron, C. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3527 · Cited by 153
Stress is critical for LPS-induced activation of microglia and damage in the rat hippocampus
Espinosa-Oliva, A. M., de Pablos, R. M., Villarán, R. F., Argüelles, S., Venero, J. L., Machado, A., & Cano, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.01.012 · Cited by 151
Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications
Rutella, S., & Lemoli, R. M. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.04.015 · Cited by 147
Bone-marrow-derived microglia: myth or reality?
Soulet, D., & Rivest, S. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.04.002 · Cited by 139
Effects of prior stress on LPS-induced cytokine and sickness responses
Johnson, J. D., O'Connor, K. A., Hansen, M. K., Watkins, L. R., & Maier, S. F. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00230.2002 · Cited by 138
Blandino, P., Barnum, C. J., Solomon, L. G., Larish, Y., Lankow, B. S., & Deak, T. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.04.013 · Cited by 137
Goujon, E., Parnet, P., Layé, S., Combe, C., & Dantzer, R. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00242-k · Cited by 128
The pituitary gland is required for protection against lethal effects of Salmonella typhimurium
Edwards, C. K., Yunger, L. M., Lorence, R. M., Dantzer, R., & Kelley, K. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2274 · Cited by 127
Hamdi, H., Godot, V., Maillot, M.-C., Prejean, M. V., Cohen, N., Krzysiek, R., Lemoine, F. M., Zou, W., & Emilie, D. (2007) · Blood · doi:10.1182/blood-2006-10-052506 · Cited by 126
Frank, M. G., Watkins, L. R., & Maier, S. F. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.01.005 · Cited by 116
Carrillo-de Sauvage, M. Á., Maatouk, L., Arnoux, I., Pasco, M., Sanz Diez, A., Delahaye, M., Herrero, M. T., Newman, T. A., Calvo, C. F., Audinat, E., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.108 · Cited by 114 · cited 2×
“This study strongly suggests that microglial GR is the principal mediator preventing neuronal degeneration triggered by LPS and that it also contributes to the protection of other cell types (177), having an important role in promoting neuronal survival.”
BackgroundMethodWeber, P. S. D., Toelboell, T., Chang, L.-C., Tirrell, J. D., Saama, P. M., Smith, G. W., & Burton, J. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003505 · Cited by 113
Turrin, N. P., & Rivest, S. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422901003 · Cited by 107
García-Bueno, B., Madrigal, J. L. M., Pérez-Nievas, B. G., & Leza, J. C. (2008) · Endocrinology · doi:10.1210/en.2007-0482 · Cited by 97
Nadeau, S., & Rivest, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3370 · Cited by 94
Nakamura, N., Shimaoka, Y., Tougan, T., Onda, H., Okuzaki, D., Zhao, H., Fujimori, A., Yabuta, N., Nagamori, I., Tanigawa, A., et al. (2006) · DNA Research · doi:10.1093/dnares/dsl006 · Cited by 94
Luther, C., Adamopoulou, E., Stoeckle, C., Brucklacher-Waldert, V., Rosenkranz, D., Stoltze, L., Lauer, S., Poeschel, S., Melms, A., & Tolosa, E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802046 · Cited by 93
Lannan, E. A., Galliher-Beckley, A. J., Scoltock, A. B., & Cidlowski, J. A. (2012) · Endocrinology · doi:10.1210/en.2012-1020 · Cited by 91
Inhibition of microglial cell activation by cortisol
Drew, P. D., & Chavis, J. A. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00275-6 · Cited by 88 · cited 13×
“Studies also demonstrated that GCs inhibit the release of pro-inflammatory mediators in microglial cells treated with LPS (169, 170).”
BackgroundInfluentialButler, L. D., Layman, N. K., Riedl, P. E., Cain, R. L., Shellhaas, J., Evans, G. F., & Zuckerman, S. H. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90108-2 · Cited by 83
Besedovsky, L., Born, J., & Lange, T. (2014) · The FASEB Journal · doi:10.1096/fj.13-237958 · Cited by 81
MK-801 and 7-Ni attenuate the activation of brain NF-κB induced by LPS
Glezer, I., Munhoz, C. D., Kawamoto, E. M., Marcourakis, T., Avellar, M. C. W., & Scavone, C. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00279-x · Cited by 79
Corticosterone impairs dendritic cell maturation and function
Elftman, M. D., Norbury, C. C., Bonneau, R. H., & Truckenmiller, M. E. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02637.x · Cited by 79
Neuro-hormonal host defence in endotoxin shock
Ramachandra, R. N., Sehon, A. H., & Berczi, I. (1992) · Brain, Behavior, and Immunity · doi:10.1016/0889-1591(92)90015-g · Cited by 79
Purton, J. F., Monk, J. A., Liddicoat, D. R., Kyparissoudis, K., Sakkal, S., Richardson, S. J., Godfrey, D. I., & Cole, T. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3816 · Cited by 79
Cao, Y., Bender, I. K., Konstantinidis, A. K., Shin, S. C., Jewell, C. M., Cidlowski, J. A., Schleimer, R. P., & Lu, N. Z. (2013) · Blood · doi:10.1182/blood-2012-05-432336 · Cited by 76 · cited 1×
“The distinct actions exerted by GCs in immature and mature DCs are due to differential expression of GR translational isoforms (126).”
BackgroundEmerging pathways of non-genomic glucocorticoid (GC) signalling in T cells
Boldizsar, F., Talaber, G., Szabo, M., Bartis, D., Palinkas, L., Nemeth, P., & Berki, T. (2010) · Immunobiology · doi:10.1016/j.imbio.2009.10.003 · Cited by 76
Blais, V., Turrin, N. P., & Rivest, S. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03480.x · Cited by 72
Inescapable shock induces resistance to the effects of dexamethasone
O’Connor, K. A., Johnson, J. D., Hammack, S. E., Brooks, L. M., Spencer, R. L., Watkins, L. R., & Maier, S. F. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00035-5 · Cited by 69
Howell, M. P., & Muglia, L. J. (2006) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.05.001 · Cited by 46
Goujon, E., Parnet, P., Cremona, S., & Dantzer, R. (1995) · Brain Research · doi:10.1016/0006-8993(95)01041-9 · Cited by 45
Fischer, H. J., Schweingruber, N., Lühder, F., & Reichardt, H. M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.001 · Cited by 34
Park, J., Kim, M., Na, G., Jeon, I., Kwon, Y.-K., Kim, J.-H., Youn, H., & Koo, Y. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.08.002 · Cited by 26
Blais, V., Zhang, J., & Rivest, S. (2002) · Endocrinology · doi:10.1210/en.2002-220598 · Cited by 22 · cited 2×
“This same effect took place when the GR antagonist RU486 was administrated (172, 173).”
BackgroundHolownia, A., Mroz, R. M., Kolodziejczyk, A., Chyczewska, E., & Braszko, J. J. (2009) · European journal of medical research · doi:10.1186/2047-783x-14-s4-108 · Cited by 20 · cited 1×
“FKBP51 expression was found to be enhanced in sputum samples from patients with chronic obstructive pulmonary disease (65).”
Background
Metadata
- Authors
- Liberman, A. C., Budziñski, M. L., Sokn, C., Gobbini, R. P., Steininger, A., & Arzt, E.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2018-05-16
- Volume
- 9
- Pages
- 235-235
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W2800565928
- Cited by
- 181
- References
- 91
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.